Skip to main content
. 2024 Apr 20;9(5):102994. doi: 10.1016/j.esmoop.2024.102994

Figure 1.

Figure 1

PFS per BICR in the (A) ITT population and by IMDC favourable (B), intermediate (C), poor (D) and intermediate/poor combined (E) risk group (IRT). BICR, blinded independent central review; CI, confidence interval; HR, hazard ratio; IMDC, International Metastatic Renal Cell Carcinoma Database Consortium; IRT, interactive response technology; ITT, intent-to-treat; NIVO + CABO, nivolumab plus cabozantinib; PFS, progression-free survival; SUN, sunitinib.aStratified Cox proportional hazard model used for HR. bUnstratified Cox proportional hazard model used for HR.